Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...

Hannah Goetz was 17 when she had a double lung transplant. Her tacrolimus medication was supposed to help her body accept her ...

The price of semaglutide drugs could drop by more than 65% when generic versions of Ozempic and Wegovy hit shelves — possibly ...

Health Canada is reviewing nine submissions for generic versions of semaglutide, a prescription medication sold under Novo ...

Generic drugmakers in India are revising pricing plans after Denmark’s Novo Nordisk slashed costs for its weight-loss ...

According to Nuvama, the increased competitive intensity following this approval is negative for Cipla, as it raises the risk ...

Generic drugmakers target a Rs 5000 crore semaglutide opportunity post-patent expiry, facing regulatory challenges in export ...

While the details of ‘The Great Healthcare Plan’ is not clear, a White House statement said it calls for codifying the Trump ...

Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and ...